Axillary Lymph Node Dissection for Melanoma



Axillary Lymph Node Dissection for Melanoma


Michael S. Sabel





PATIENT HISTORY AND PHYSICAL FINDINGS



  • The history should focus on the patient’s melanoma history, including the histology of the primary tumor, disease-free interval between the primary diagnosis and the diagnosis of regional metastases, and the extent of both locoregional and distant disease. The history should also focus on comorbidities, past medical history, and medications that might impact the patient’s surgical candidacy.






    FIG 1 • Levels of axillary lymph nodes. The level I nodes are located lateral to the pectoralis minor muscle, the level II nodes are located deep to the pectoralis minor, whereas the level III nodes are located medial to the pectoralis minor.


  • The history should also include a thorough review of systems, specifically looking for symptoms suggestive of distant disease. Patients with symptoms worrisome for stage IV disease should have body imaging before proceeding with surgery.


  • A complete physical examination should pay particular attention to signs of local, regional, and distant disease. The site of the primary tumor and the skin between it and the regional basin should be examined for signs of in-transit recurrences. A complete lymph node exam should be performed. This should not just be limited to the axilla of concern but bilateral cervical, supraclavicular, epitrochlear, axillary, and inguinal basins. Suspicious nodes outside of the draining basins may represent stage IV disease.


  • For the involved axilla, the exam should focus on the extent of disease, including the size of the involved nodes and fixation. The ipsilateral arm should be examined for lymphedema, weakness, or sensory deficit, as these may be indicative of involvement of the axillary vein or brachial plexus. You should also document any conditions affecting the shoulder or upper extremity, which limits range of motion.


  • For patients who had an SLN biopsy or excisional biopsy, it is important to document any sensory or motor deficits that may have occurred at the first surgery as well as any seroma, hematoma, or infection. It may also be helpful to note the orientation of the incision, as this may impact the orientation of the ALND incision.


  • It is important to review with patients the expected postoperative course including drain management and arm exercises, as well as short-term and long-term morbidity, including the risk, prevention, and management of lymphedema.


IMAGING AND OTHER DIAGNOSTIC STUDIES



  • For asymptomatic patients with micrometastatic disease identified on SLN biopsy, there are no imaging studies necessary before proceeding with ALND.3 For patients with thick, ulcerated tumors (American Joint Commission Center [AJCC] stage T4b) and a positive SLN, the risk of distant disease may justify preoperative body imaging, with either a computed tomography (CT) scan or positron emission tomography (PET)/CT.4 However, for patients with micrometastatic disease, preoperative staging studies have a high false-positive rate, may lead to unnecessary follow-up studies or biopsies, and rarely alter surgical decision making.


  • Patients with symptoms concerning for metastatic disease should undergo staging with either a CT of the chest, abdomen, and pelvis or a PET/CT and a magnetic resonance imaging (MRI) of the brain. Patients with clinically evident regional disease should also undergo distant staging, as there
    is a higher chance of detecting metastatic disease that might alter surgical decision making.3


  • For patients with fixed, matted lymph nodes; skin involvement; or neurovascular symptoms of the involved arm (paresthesias, motor and sensory deficits, lymphedema, limited range of motion), MRI of the chest wall can be helpful in determining resectability. Unresectable or borderline resectable patients could be considered for neoadjuvant therapy with newer biologic and targeted therapies.


SURGICAL MANAGEMENT


Preoperative Planning



  • In the preoperative area, the side of the ALND should be clearly marked and confirmed with the patient before proceeding to the operating room (OR).


  • Intravenous (IV) antibiotics are indicated for ALND.5 Sequential compression devices (SCDs) should be used for deep venous thrombosis (DVT) prophylaxis. Patients with a history of DVT or genetic predisposition toward clotting should receive subcutaneous heparin.


  • Many surgeons prefer the use of short-acting neuromuscular blocking agents during induction, so that the patients are not paralyzed during the procedure. This allows identification of the thoracodorsal, long thoracic, and medial and lateral pectoral nerves by mechanical stimulation. However, this is not essential and some surgeons prefer paralysis with a longacting neuromuscular blocking agent to prevent muscular contraction and allow for retraction of the pectoralis major and minor muscles. Either way, this should be discussed with the anesthesiologist prior to the case.


Positioning



  • The patient should be positioned supine on the OR table, toward the edge of the side of the ALND so that the posterior axillary line is in-line with the edge of the table. The ipsilateral arm is abducted at 90 degrees on a padded arm board. It is important not to extend the arm past 90 degrees to avoid brachial plexus injury.


  • The endotracheal tube should be located away from the involved arm and adequate space should be preserved above the arm for the surgical assistant.


  • The chest wall, lower neck, and entire arm should be prepped and draped into the surgical field using a sterile stockinette and Kerlix wrap. This allows the arm to be rotated over the chest, relaxing the pectoralis major and minor (FIG 2).






FIG 2 • Preoperative positioning and draping for an ALND. The arm should be prepped into the field with a stockinette and Kerlix wrap so it can be rotated over the chest during the procedure.

Jul 24, 2016 | Posted by in GENERAL SURGERY | Comments Off on Axillary Lymph Node Dissection for Melanoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access